{{customText[Hi|Hello|Dear
|Good morning|Good afternoon]}} {{customText[Dr.|Doctor
|Mr.|Ms.]}} {{customText[##accLname##:
|##accFname##:|
##accFname##
##accLname##:]}}

I am writing you today with exciting news that Exact Sciences is releasing a new Oncotype DX Genomic Prostate Score^® (GPS^™) Report for Unfavorable Intermediate and High Risk Groups on June 11th. With different clinical decisions in localized prostate cancer, you and your patients need tailored genomic reports with the relevant endpoints to help inform the treatment decision at hand. Choices which impact patient quality of life within a given clinical guideline, such as radiation intensity or how long to use hormone therapy, may be easier to make with more refined information on tumor aggressiveness and expected adverse outcomes.

The new Genomic Prostate Score^® (GPS) high-risk report provides 10-year risk of distant metastasis and death generated from both RP and RT treated patients to help inform decisions on treatment intensity for your unfavorable intermediate and high-risk patients.

I would like to invite you to attend a {{customText[breakfast|lunch]}} meeting to learn how the new report can be used to help you and your patients make informed decisions around multi-modal therapy. If you know of another healthcare professional who might also be interested in attending, please let me know.

Please confirm your availability for an upcoming meeting at your earliest convenience. Also, note that we do need a confirmation of your attendance via a response to this invite by {{customText(200)}} before we can order a {{customText[breakfast|lunch]}} for you.

Looking forward to our conversation.

{{customText[Regards|Best|My best|Talk to you soon|See you soon|Thanks|Thank you]}},

{{userName}}
{{User.Title}}
{{User.Phone}}
{{userEmailAddress}}

This invitation is only intended for the healthcare professional addressed above and should not be forwarded to others. If you would prefer not to receive invitations by e-mail from me in the future, please respond to this e-mail with your request